Page 50 - Anjali Singh

Aston Martin to double its volume with new South India dealership

Aston Martin's decision to expand its footprint in South India reflects a strategic choice, due to the region's growth in the sports car segment

Valvoline targets double-digit market share growth in India over 5 years

The company is striving to establish a comprehensive ecosystem for its customers, offering a full spectrum of products, including lubricants, grease, diesel exhaust fuel, and more

DCGI approves MSD India's drug KEYTRUDA for breast cancer in adult patients

Renal cell carcinoma (RCC), the most common type of kidney cancer, predominantly affects men and has limited treatment options, often leaving patients at risk of recurrence

Torrent Pharma Q2 results: Profit after tax up 24% to Rs 386 crore

The company exhibited a 2.66 per cent increase in revenue and was able to turn around the PAT by 2.09 per cent

Breast cancer strikes younger Indian women at an alarming rate: Study

A striking 25 per cent of breast cancer cases among Indian women occurred at the age of 39 years or younger

Supriya Life targets 1-2% global mkt share with oral cancer detection kit

Quickblue is designed to detect oral cancer swiftly, eliminating the need for extensive preclinical and clinical trials

Deep discounts on offer to light up car sales in India before Diwali

Average October discounts are up 40-50% compared to last year

Glenmark Life Sciences Q2 results: PAT rises 11%, revenue up 16.9%

Generic API revenues increased by 19.7 percent this quarter due to growth in US, LATAM and Europe regulated markets

Himadri Speciality Chemical reports 5.1% revenue decline in Q2FY24

Operating in both domestic and international markets, Himadri Speciality Chemical exports to 49 countries worldwide

Glenmark gets USFDA nod to market generic version of Otezla tablets

Glenmark's current portfolio includes a total of 188 products that have been authorised for distribution in the US marketplace

Zydus appoints Punit Patel as President & CEO for North American Operations

Punit Patel brings over 20 years of experience in both generic and branded pharmaceutical sectors

Ichnos Sciences, Astria Therapeutics sign licensing deal for OX40 portfolio

Ichnos is set to receive $320 million upfront for development, regulatory and sales payments, coupled with low double-digit royalties

Excess vaccine-making capacity may get utilised in 3-5 years: Merck Life

Some 40-50 firms in India are getting into mRNA technology, says Aditya Sharma, senior executive of the German company

Mental health: Women opt for teleconsultations, while men prefer in-person

According to the WHO, India bears a significant mental health burden of 2,443 disability-adjusted life years (DALYs) per 100,000 population

Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada

Under the agreement's terms, Biocon will be responsible for obtaining regulatory approvals for Liraglutide and will subsequently manage the manufacturing and distribution of the product within Canada

US FDA approves NDA for Sun Pharma's alopecia drug Deuruxolitinib

Sun Pharma's NDA submission comprised data from two Phase-III trials, 'THRIVE-AA1' and 'THRIVE-AA2,' involving over 1,200 patients across more than 135 clinical trial sites

Cytiva opens new manufacturing facility and experience center in Pune

The newly unveiled manufacturing facility in Pune will produce bioprocessing equipment, including tangential flow, virus filtration, and inactivation systems

India can become $1 trn export-led automotive hub by 2035: Report

India is the fourth-largest global automotive market, generating $250 billion in FY23 and contributing 7.3 per cent to the national GDP

Schedule M likely to be revised to bring it closer to WHO standards

The draft rules, still under consideration, include provisions to strengthen quality control and the safety of drugs manufactured in India

Agilus Diagnostics files for IPO to raise funds via 142.3 mn shares

The diagnostics giant partners with ICICI Securities, Axis Capital, and Citigroup for public offering, aiming to sell equity shares held by key investors